Cargando…

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Enhancer RNAs (eRNAs) are intergenic long non-coding RNAs (lncRNAs) that participate in the progression of malignancies by targeting tumor-related genes and immune checkpoints. However, the potential role of eRNAs in hepatocellular carcinoma (HCC) is unclear. In this study, we aimed to c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Shenglan, Hu, Xingwang, Chen, Ruochan, Zhang, Yiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226176/ https://www.ncbi.nlm.nih.gov/pubmed/34178028 http://dx.doi.org/10.3389/fgene.2021.657051

Ejemplares similares

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer
por: Fan, Shuaishuai, et al.
Publicado: (2021)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

EPDR1 correlates with immune cell infiltration in hepatocellular carcinoma and can be used as a prognostic biomarker
por: Chen, Ruochan, et al.
Publicado: (2020)

Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network
por: Pu, Zhangya, et al.
Publicado: (2021)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

An M0 macrophage-related prognostic model for hepatocellular carcinoma
por: Zhang, Yiya, et al.
Publicado: (2022)

Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2021)

Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma
por: Wu, Pu, et al.
Publicado: (2022)

Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
por: Zhang, Lei, et al.
Publicado: (2022)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
por: Zhou, Zhiyang, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Enhancer RNA (eRNA) in Human Diseases
por: Wang, Yunzhe, et al.
Publicado: (2022)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects
por: Wan, Lilin, et al.
Publicado: (2022)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021)

Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma
por: Wang, Gongjun, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Identification of Prognostic Stromal-Immune Score–Based Genes in Hepatocellular Carcinoma Microenvironment
por: Liu, Shanshan, et al.
Publicado: (2021)

The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
por: Hu, Xin, et al.
Publicado: (2022)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
por: Wang, Wei, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6ac93fciuac1e98ruqm4h0lp39